Fosrenol Tablet, Chewable
NDC Package 54092-252-90

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Fosrenol (lanthanum carbonate) tablets is lanthanum is used to lower high blood phosphate levels in people who are on dialysis due to severe kidney disease. This formulation utilizes a tablet, chewable delivery system. Marketed by Takeda Pharmaceuticals America, Inc., this product is identified by NDC 54092-252 and is authorized under FDA application NDA021468.

Identification & Billing

NDC Package Code
54092-252-90
Package Description
2 BOTTLE in 1 PACKAGE / 45 TABLET, CHEWABLE in 1 BOTTLE (54092-252-45)
Product Code
54092-252
11-Digit Billing Format
54092025290
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
2 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Fosrenol
Non-Proprietary Name
Lanthanum Carbonate
Substance Name
Lanthanum Carbonate
Dosage Form
Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
LANTHANUM CARBONATE 500 mg/1
Pharmacologic Class
Usage Information
Lanthanum is used to lower high blood phosphate levels in people who are on dialysis due to severe kidney disease. Dialysis removes some phosphate from your blood, but it is difficult to remove enough to keep your phosphate levels balanced. Decreasing blood phosphate levels can help keep your bones strong, prevent unsafe buildup of minerals in your body, and may decrease the risk of heart disease and strokes that can result from high phosphate levels. Lanthanum is a natural mineral that works by binding to phosphate in the foods you eat. The phosphate then passes out of your body in your stool.

Regulatory & Marketing

Labeler Name
Takeda Pharmaceuticals America, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA021468
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-26-2004
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 54092-252-90 identifies a specific commercial package of 2 bottle in 1 package / 45 tablet, chewable in 1 bottle (54092-252-45) of Fosrenol, a human prescription drug labeled by Takeda Pharmaceuticals America, Inc.. This tablet, chewable is formulated for oral use and contains lanthanum carbonate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Takeda Pharmaceuticals America, Inc. on October 26, 2004. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Lanthanum is used to lower high blood phosphate levels in people who are on dialysis due to severe kidney disease. Dialysis removes some phosphate from your blood, but it is difficult to remove enough to keep your phosphate levels balanced. Decreasing blood phosphate levels can help keep your bones strong, prevent unsafe buildup of minerals in your body, and may decrease the risk of heart disease and strokes that can result from high phosphate levels. Lanthanum is a natural mineral that works by binding to phosphate in the foods you eat. The phosphate then passes out of your body in your stool.

How is this Takeda Pharmaceuticals America, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 54092025290. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
54092-252-90
11-Digit CMS (5-4-2)
54092-0252-90

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.